Review article: COVID‐19 and liver disease—what we know on 1st May 2020
Top Cited Papers
- 13 May 2020
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 52 (2), 267-275
- https://doi.org/10.1111/apt.15813
Abstract
Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative pathogen of coronavirus disease 2019 (COVID‐19), became a global threat to human health. Liver impairment has been frequently reported as a common manifestation, although its clinical significance is still unclear, particularly in patients with underlying chronic liver disease (CLD). Aims To summarize the changes in liver function tests during SARS‐CoV‐2 infection and the impact of COVID‐19 in patients with underlying CLD. Methods A literature review using online database Pubmed was done using the search terms “SARS‐CoV‐2”, “COVID‐19”, “liver”, “cirrhosis” and “liver transplantation”. Results COVID‐19 is frequently associated with different degrees of abnormal liver function tests, most notably transaminases, which are usually transitory and of mild degree. Available evidence suggests that liver injury may result from direct pathogenic effect by the virus, systemic inflammation or toxicity from commonly used drugs in this subset of patients. SARS‐CoV‐2 infection in children is associated with minimal or no increase in liver enzymes, thus the presence of abnormal liver function tests should trigger evaluation for underlying liver diseases. Although it seems that patients with CLD are not at greater risk for acquiring the infection, those with cirrhosis, hepatocellular carcinoma, non‐alcoholic fatty liver disease, autoimmune liver diseases or liver transplant may have a greater risk for severe COVID‐19. Conclusions Abnormal liver function tests during the course of COVID‐19 are common, though clinically significant liver injury is rare. Further research is needed focusing on the effect of existing liver‐related comorbidities on treatment and outcome of COVID‐19.This publication has 77 references indexed in Scilit:
- Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevanceJournal of Hepatology, 2014
- Community acquired respiratory and gastrointestinal viral infectionsCurrent Opinion in Infectious Diseases, 2012
- Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infectionRheumatology, 2012
- Safety and Pharmacokinetics of Lopinavir in HIV/HCV Coinfected Patients with Advanced Liver DiseaseHIV Research & Clinical Practice, 2011
- Systemic Viral Infections and Collateral Damage in the LiverThe American Journal of Pathology, 2006
- Overexpression of 7a, a Protein Specifically Encoded by the Severe Acute Respiratory Syndrome Coronavirus, Induces Apoptosis via a Caspase-Dependent PathwayJournal of Virology, 2004
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Drug-Induced Liver Injury Associated with Antiretroviral Therapy that Includes HIV-1 Protease InhibitorsClinical Infectious Diseases, 2004
- SARS-associated viral hepatitis caused by a novel coronavirus: Report of three casesJournal of Hepatology, 2004
- Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1990